D. Tindall
Genetics · 2007–2013
A researcher in the Science corpus: 4 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
Whom D. Tindall trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from D. Tindall's perspective
Ordered by how strongly the researchers D. Tindall trusts endorse each paper. Same corpus, a different order for every researcher.
- Molecular determinants of resistance to antiandrogen therapy (Nature Medicine)
- Androgen receptor (AR) coregulators: an overview. (Endocrine reviews)
- LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription (Nature)
- Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. (Science)
- A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. (Molecules and Cells)
- Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. (Cancer Cell)
- A molecular signature of metastasis in primary solid tumors (Nature Genetics)
- Gene expression profiling identifies clinically relevant subtypes of prostate cancer. (Proceedings of the National Academy of Sciences of the United States of America)
- Addendum: Regularization and variable selection via the elastic net
- Regularization Paths for Generalized Linear Models via Coordinate Descent
Their papers
- Splicing of a novel AR exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance (2008) — 807 citations
- Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy (2013) — 661 citations
- Effect of dutasteride on the risk of prostate cancer. (2010) — 1,111 citations
- Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. (2007) — 735 citations